Table 2

Changes in disease activity, hospitalizations and steroid dosing pre and post transfer.

Disease Activity

Pre-Transfer

Post-Transfer

P value


Median (range) SLEDAI score*

4 (0–16)

4 (0–20)

0.3


Disease activity**


None

12 (80)

10 (67)

Mild/moderate

2 (13)

4 (27)

0.16

Severe

1 (7)

1 (7)


Number of Hospitalizations*

Total

32

6

0.017

Scheduled

21

2

0.03

Flare associated

8

4

0.26


Steroid Dosing

Median prednisone dose at last visit, mg (range)

5 (0–40)

2 (0–20)

0.004

Median peak prednisone dose, mg (range)

10 (0–60)

5 (0–60)

0.059

IV methylprednisolone, No (%)

3 (10)

4 (13)

0.99


* Systemic Lupus Erythematosus (n = 16)

**MCTD, APLS, Vasculitis, Spondylarthropathy (n = 15)

IV = Intravenous

Hersh et al. Pediatric Rheumatology 2009 7:13   doi:10.1186/1546-0096-7-13

Open Data